Literature DB >> 526461

Intraocular pressure reduction in chronic simple glaucoma by continuous infusion of dilute pilocarpine solution.

A T Birmingham, N R Galloway, D A Walker.   

Abstract

Ten hospital outpatients with bilateral chronic simple glaucoma received a single drop of 2% pilocarpine to one eye and a continuous infusion of 0.1 % pilocarpine at a flow rate of 0.01 ml/min to the other eye (both solutions were at pH 7.2). On another occasion the treatments were reversed. Measurements of intraocular pressure (IOP) and pupil diameter were made at 30 min intervals for 2 hours. The continuous infusion of dilute solution was as effective as the single drop of more concentrated solution in reducing IOP and in constricting the pupil; the drop was somewhat faster in producing its effect.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526461      PMCID: PMC1043631          DOI: 10.1136/bjo.63.12.808

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Continuous infusion of the conjunctival sac with pilocarpine in normal subjects and in patients with chronic glaucoma.

Authors:  A T Birmingham; N R Galloway; S A Spencer; D A Walker
Journal:  Trans Ophthalmol Soc U K       Date:  1976-07

2.  A comparison of the pupilloconstrictor effect of pilocarpine solution administered to the conjunctival sac as a single drop or as a continuous infusion in normal subjects.

Authors:  A T Birmingham; N R Galloway; S A Spencer
Journal:  Br J Ophthalmol       Date:  1976-08       Impact factor: 4.638

3.  The role of the cornea in the biologic response to pilocarpine.

Authors:  M C Van Hoose; F E Leaders
Journal:  Invest Ophthalmol       Date:  1974-05

4.  [The significance of the form of application and concentration for the persistence of pilocarpine and eserine in the conjunctival sac and the aqueous humor].

Authors:  H Schumacher
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1966-03-17

5.  The dose response of human intraocular pressure to pilocarpine.

Authors:  S M Drance; P A Nash
Journal:  Can J Ophthalmol       Date:  1971-01       Impact factor: 1.882

6.  Influence of pH on the effect of pilocarpine on aqueous dynamics.

Authors:  R A Anderson; J B Cowle
Journal:  Br J Ophthalmol       Date:  1968-08       Impact factor: 4.638

7.  Dose-response relationships for the clinical and pharmaceutical evaluation of glaucoma drugs.

Authors:  J B Cowle; R A Anderson
Journal:  Trans Ophthalmol Soc Aust       Date:  1967

8.  Pilocarpine and intraocular pressure. Duration of effectiveness of 4 percent and 8 percent pilocarpine instillation.

Authors:  S M Drance; M Bensted; M Schulzer
Journal:  Arch Ophthalmol       Date:  1974-02

9.  Continuous infusion of the conjunctival sac with chloramphenicol in preoperative cataract patients.

Authors:  G F Bedford; A T Birmingham; N R Galloway
Journal:  Trans Ophthalmol Soc U K       Date:  1976-07

10.  THE DIFFERENCE IN OCULAR PRESSURE IN THE TWO EYES OF THE SAME PERSON: IN INDIVIDUALS WITH HEALTY EYES AND IN PATIENTS WITH GLAUCOMA SIMPLEX.

Authors:  M DAVANGER
Journal:  Acta Ophthalmol (Copenh)       Date:  1965
  10 in total
  1 in total

1.  Consensual pupillary responses to mydriatic and miotic drugs.

Authors:  N Theofilopoulos; J Longmore; F A Kerr; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.